Literature DB >> 19636593

Evaluation of certain constituents of antioxidant defense in youth treated in the past for steroid-sensitive idiopathic nephrotic syndrome.

Maria Hanna Kniazewska1, Anna Karolina Obuchowicz, Tomasz Wielkoszyński, Joanna Zmudzińska-Kitczak, Katarzyna Urban, Lidia Hyla-Klekot.   

Abstract

Disorders of lipid metabolism and antioxidant defense capacity reported during idiopathic nephrotic syndrome (INS) exacerbations are known. The aim of this study was to evaluate constituents of antioxidant defense [total antioxidant potential: ferric-reducing antioxidant power (FRAP), paraoxonase-1 (PON-1), tocopherols, ascorbic acid] in patients formerly treated for INS. The studied group consisted of 30 patients (20 males and 10 females) treated 4-15 years ago for INS. The control group consisted of 30 healthy teenagers. There were no statistically significant differences in PON-1 activity (156.4 +/- 97.1 vs 137.7 +/- 80.2 U/l), alpha-tocopherol levels (23.9 +/- 7.3 vs 22.4 +/- 3.2 micromol/l) and sum of beta- and gamma-tocopherols (2.1 +/- 1.0 vs 2.3 +/- 0.6 micromol/l), and in FRAP (484.9 +/- 87.2 vs 452.8 +/- 76.9 micromol/l) between groups. In the study group, a significantly lower concentration of ascorbic acid (53.0 +/- 20.8 vs 69.4 +/- 16 micromol/l; p < 0.002), decreased values of alpha-tocopherol/cholesterol (4.9 +/- 0.7 vs 5.5 +/- 1.2; p = 0.03), and total tocopherol/cholesterol (5.3 +/- 0.8 vs 6.1 +/- 1.4; p = 0.016) ratios were observed. A positive correlation between tocopherol/total cholesterol (TCh) (r = 0.41; p < 0.05) and alpha-tocopherol/TCh (r = 0.50; p < 0.001) ratios and INS relapse frequency was reported. The relationship between the study parameters and group of variables (relapse frequency, duration of the last remission, age, gender) was tested using the multiple linear regression analysis. The results of this study suggest that the nonenzymatic antioxidant defense in young persons formerly treated for INS is weaker than in their healthy counterparts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636593     DOI: 10.1007/s00467-009-1269-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

Review 1.  Role of reactive oxygen species in glomerulonephritis.

Authors:  W Gwinner; H J Gröne
Journal:  Nephrol Dial Transplant       Date:  2000-08       Impact factor: 5.992

2.  Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis.

Authors:  Y Frishberg; H Toledano; R Becker-Cohen; E Feigin; D Halle
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

3.  Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis.

Authors:  B Skrzep-Poloczek; A Tomasik; R Tarnawski; L Hyla-Klekot; A Dyduch; C Wojciechowska; W Wesolowski; E Kopieczna-Grzebieniak; J Zalejska-Fiolka; E Widera
Journal:  Nephron       Date:  2001-09       Impact factor: 2.847

4.  Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.

Authors:  Marguerite M Engler; Mary B Engler; Mary J Malloy; Elisa Y Chiu; Monique C Schloetter; Steven M Paul; Markus Stuehlinger; Ken Y Lin; John P Cooke; Jason D Morrow; Paul M Ridker; Nader Rifai; Elizabeth Miller; Joseph L Witztum; Michele Mietus-Snyder
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

5.  Paraoxonase activity in glomerulonephritic patients.

Authors:  Mustafa Gullulu; Serdar Kahvecioglu; Melahat Dirican; Ibrahim Akdag; Nihal Ocak; Celalettin Demircan; Kamil Dilek; Alpaslan Ersoy; Mahmut Yavuz; Mustafa Yurtkuran
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

6.  Oxidative stress status in children with nephrotic syndrome.

Authors:  A Rajbala; A S Sane; J Zope; V V Mishra; H L Trivedi
Journal:  Panminerva Med       Date:  1997-09       Impact factor: 5.197

7.  Apoptosis and antioxidant defense in the nephrotic syndrome.

Authors:  Jacek Zachwieja; Waldemar Bobkowski; Marcin Zaniew; Agnieszka Dobrowolska-Zachwieja; Maria Lewandowska-Stachowiak; Aldona Siwińska
Journal:  Pediatr Nephrol       Date:  2003-09-05       Impact factor: 3.714

8.  Anti-oxidant vitamins and steroid responsive nephrotic syndrome in Indian children.

Authors:  J L Mathew; B C Kabi; B Rath
Journal:  J Paediatr Child Health       Date:  2002-10       Impact factor: 1.954

9.  Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome.

Authors:  Maria H Kniazewska; Anna K Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Marta Marek; Jolanta Witanowska; Karolina Sieroń-Stołtny
Journal:  Pediatr Nephrol       Date:  2008-10-30       Impact factor: 3.714

10.  Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome.

Authors:  Jacek Zachwieja; Waldemar Bobkowski; Agnieszka Dobrowolska-Zachwieja; Marcin Zaniew; Janusz Maciejewski
Journal:  Med Sci Monit       Date:  2003-06
View more
  2 in total

1.  Paraoxonase Activity and Lipid Profile in Paediatric Nephrotic Syndrome: A Cross-sectional Study.

Authors:  Vijayetha P Patil; Anuradha B Patil; Vidya S Patil; Deepti G Ingleshwar
Journal:  J Clin Diagn Res       Date:  2016-03-01

2.  Evaluation of paraoxonase activity in children with nephrotic syndrome.

Authors:  Mohammad Hashemi; Simin Sadeghi-Bojd; Mohsen Raeisi; Abdolkarim Moazeni-Roodi
Journal:  Nephrourol Mon       Date:  2013-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.